Please review the upcoming Test Changes, share updates with colleagues and staff members as appropriate, and implement necessary workflow changes by the specified effective dates.
|
| Effective Date | Test ID
Test Name | Change Type & File |
|---|
| February 25, 2026 | LAB8883
Brivaracetam QT-ARUP |
NEW TEST
| | February 25, 2026 | LAB8879
Certolizumab and Anti-Certolizumab Antibody, DoseASSURE™ CTZ-LCOR
| NEW TEST |
| February 25, 2026 | LAB8880
Etanercept and Anti-Etanercept Antibody, DoseASSURE™ ETN-LCOR
| NEW TEST |
| February 11, 2026 | LAB8520
Genetics Misc Ref Test
|
NEW TEST | | February 25, 2026 | LAB881
Human Immunodeficiency Virus 1 (HIV-1) GenoSure Archive-LCOR
| NEW TEST | | February 16, 2026 | LAB75
Immunoglobulin M, Plasma or Serum
| REFERENCE INTERVAL | | February 11, 2026 | LAB6342
Pharmacogenetic Panel | COMPONENT CHANGE | | February 25, 2026 | LAB8882
TPSAB1 Copy Number Analysis by ddPCR-ARUP
| NEW TEST | | March 25, 2026 | LAB8620
Vitamin D, 1,25-Dihydroxy (Hypercalcemia/Renal Disease)
| NEW TEST |
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
445 Great Circle Rd | Nashville, TN 37228 US
|
|
|
This email was sent to tom.peters@vumc.org.
To continue receiving our emails, add us to your address book.
|
|
|
|
